Incyte sells Jakafi for bone-marrow disorders.
Incyte Corporation (INCY) is expected to report earnings on Thursday, October 29, 2026, before the open. Estimated release time 07:03 ET. Consensus EPS estimate is $-3.51.
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| 2026-07-28 | Jun 2026 qtr | $2.15 | $3.09 | — | $1.67B |
| 2026-04-28 | Mar 2026 qtr | $1.34 | $1.81 | — | $1.27B |
| 2026-02-10 | Dec 2025 qtr | $1.90 | $1.80 | -5.3% | $1.51B |
| 2025-10-28 | Sep 2025 qtr | $1.66 | $2.26 | — | $1.37B |
| 2025-07-29 | Jun 2025 qtr | $1.39 | $1.57 | +12.9% | $1.22B |
| 2025-04-29 | Mar 2025 qtr | $1.01 | $1.16 | +14.9% | $1.05B |
| 2025-02-10 | Dec 2024 qtr | $1.57 | $1.43 | -8.9% | $1.18B |
| 2024-10-29 | Sep 2024 qtr | $1.12 | $1.07 | -4.5% | $1.14B |
INCY has beaten consensus EPS in 2 of its last 5 scored quarters.
See INCY on the live calendar →